Cargando…

Recurrence Risk Factors Analysis for Stage I Non-small CellLung Cancer: Erratum

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616827/ http://dx.doi.org/10.1097/01.md.0000472178.01382.79

Ejemplares similares

Radiation-induced eosinophil increase ratio predicts patient outcomes in non-small celllung cancer
por: Wang, Nuo-Han, et al.
Publicado: (2022)

Erratum to: Sub-classification of Stage II colorectal cancer based on clinicopathological risk factors for recurrence
por: Hashimoto, Takuzo, et al.
Publicado: (2014)

Role of surgery in patients with early stage small-cell lung cancer [Erratum]
Publicado: (2019)

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2013)

Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2020)

Erratum to efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
Publicado: (2022)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer: Erratum
Publicado: (2016)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2023)

Erratum to: Preoperative risk factors for early recurrence after resection of perihilar cholangiocarcinoma
Publicado: (2022)

Prognostic Value of Metastatic N1 Lymph Node Ratio and Angiolymphatic Invasion in Patients With Pathologic Stage IIA Non-Small Cell Lung Cancer: Erratum
Publicado: (2016)

Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study
por: Ma, Xiaowen, et al.
Publicado: (2018)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis: Erratum
Publicado: (2015)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro [Erratum]
Publicado: (2018)

Management of and risk factors for regional recurrence in upper lip squamous cell carcinoma: Erratum
Publicado: (2018)

Erratum: Risk Factor Analysis for the Recurrence of Chronic Subdural Hematoma: A Review of 368 Consecutive Surgical Cases
por: Oh, Chang Wan
Publicado: (2017)

Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum
Publicado: (2016)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma: Erratum
Publicado: (2017)

Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
Publicado: (2022)

Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study
por: Jochems, Sylvia H.J., et al.
Publicado: (2020)

Erratum to: An updated review of case–control studies of lung cancer and indoor radon-Is indoor radon the risk factor for lung cancer?
por: Sheen, Seungsoo, et al.
Publicado: (2016)

Erratum to the association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer
Publicado: (2022)

Erratum to SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway
Publicado: (2022)

Erratum to: Clustering of non-communicable diseases risk factors in Bangladeshi adults: an analysis of STEPS survey 2013
por: Zaman, M. Mostafa, et al.
Publicado: (2015)

Erratum: Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
por: Sheng, Jin, et al.
Publicado: (2016)

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
por: Hu, Xingsheng, et al.
Publicado: (2020)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
por: Wang, Huan, et al.
Publicado: (2014)

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
por: Feng, Liang, et al.
Publicado: (2016)

Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity
por: Zhang, Hongye, et al.
Publicado: (2020)

Erratum: Isolated humeral recurrence in endometrial carcinoma
Publicado: (2016)

Erratum: Recurrent Adult Nasal Dermoid Cyst
Publicado: (2017)

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection
por: Snee, M. P., et al.
Publicado: (2016)

ERRATUM: Non-Anatomic Proximal Realignment for Recurrent Patellar Dislocation Does Not Sufficiently Prevent Redislocation
Publicado: (2012)

Erratum to evaluation of PD-L1 expression on circulating tumour cells in small cell lung cancer
Publicado: (2022)

Erratum to: PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer
por: Han, Ji-Youn, et al.
Publicado: (2016)

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
por: Remon, Jordi, et al.
Publicado: (2017)

Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
por: Wang, Yuxiang, et al.
Publicado: (2019)

miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer: Erratum
por: Liu, Xiaomin, et al.
Publicado: (2023)

Erratum: Isolated neurofibroma of the eyelid mimicking recurrent chalazion
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k5akarj54i5baj3dicra0cvooq